Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Resolving metabolic interactions between the gut microbiota and the host with multi-omics-based modelling

Project description

Deciphering gut microbiota-host interactions for targeted intervention

The gut microbiota plays a vital role in health by aiding digestion, absorbing nutrients and supporting the immune system and brain function. Since dietary and therapeutic interventions can modify the gut microbiota, their regulation could improve health and prevent disease. However, the microbial diversity that makes up the gut microbiota differs in each person, making it difficult to predict how alterations would affect the host. Using multiomics-based modelling, the ERC-funded MetaboGutModel project will investigate bacterial metabolic functions, molecular interactions within microbial communities and the mechanisms of microbial interactions. It will then provide a framework to systematically resolve the microbiota contributions to the host metabolic phenotype, thus enabling targeted microbiota interventions.

Objective

The gut microbiota is essential to human health: microorganisms in the human body help to digest nutrients, engage in host metabolism, immunity, behaviour and brain functions. Since the gut microbiota, in contrast to the human genome, can be modified through dietary and therapeutic interventions, modulating the microbiota is a promising path to improve human health and to prevent or treat diseases. However, predicting the effects of microbiota perturbations on the host metabolic phenotype remains extremely challenging due to our limited understanding of bacterial metabolic functions, molecular interactions within microbial communities, and the mechanisms of microbial interactions with the host.
I propose to tackle these challenges with a combination of experimental and computational approaches in a synthetic community of 14 common human gut bacteria, which has been associated with > 150 health-relevant metabolites involved in amino acid, vitamin, and hormone metabolism in vivo. We will follow a bottom-up strategy to i) systematically characterize the capacity of single bacteria to consume and produce metabolites of interest and identify the responsible enzymes; ii) investigate the metabolism of these compounds in compositionally diverse synthetic communities; and iii) quantify and modulate microbiota contribution to the host metabolism of these compounds in mouse models. To this aim, we will combine high-throughput bacterial culturing, metabolomics, transcriptomics and proteomics assays with genome-scale metabolic modelling, graph-based multi-omics integration methods and physiology-based models of microbiota-host interactions. This project will provide a generalized framework to systematically resolve microbiota contributions to the host metabolic phenotype, and elucidate the fundamental principles governing microbiota-host metabolic interactions, thus enabling targeted microbiota interventions to modulate the host metabolic phenotype and improve human health.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2023-STG

See all projects funded under this call

Host institution

EUROPEAN MOLECULAR BIOLOGY LABORATORY
Net EU contribution
€ 1 499 323,75
Address
Meyerhofstrasse 1
69117 Heidelberg
Germany
Region
Baden-Württemberg Karlsruhe Heidelberg, Stadtkreis
Activity type
Research Organisations
Links
Total cost
€ 1 499 323,75

Beneficiaries (1)